Opexa Therapeutics Supports National Multiple Sclerosis Society And Walk MS
THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders, including multiple sclerosis (MS) and neuromyelitis optica (NMO), today announced its partnership with the National Multiple Sclerosis Society, Lone Star Chapter, as a sponsor of the nonprofit’s annual Houston area Walk MS fundraisers for the fourth consecutive year.
Opexa is supporting the Walk MS program for the Society’s Texas Lone Star Chapter, which serves more than 68,000 individuals affected by MS in Texas. The Houston area fundraisers take place throughout October and November and consist of four local walks, including in The Woodlands, the location of Opexa’s corporate headquarters.
Help employers find you! Check out all the jobs and post your resume.
Opexa is supporting the Walk MS program for the Society’s Texas Lone Star Chapter, which serves more than 68,000 individuals affected by MS in Texas. The Houston area fundraisers take place throughout October and November and consist of four local walks, including in The Woodlands, the location of Opexa’s corporate headquarters.
Help employers find you! Check out all the jobs and post your resume.